Cargando…

PI3K/Akt/mTOR Signaling Pathway in Blood Malignancies—New Therapeutic Possibilities

SIMPLE SUMMARY: The PI3K/Akt/mTOR pathway plays a crucial role in cancer, including leukemia. Abnormalities in this pathway drive carcinogenesis by inducing uncontrolled growth, increased survival, and treatment resistance. The abovementioned pathway is also disrupted in various types of leukemia, w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wiese, Wojciech, Barczuk, Julia, Racinska, Olga, Siwecka, Natalia, Rozpedek-Kaminska, Wioletta, Slupianek, Artur, Sierpinski, Radoslaw, Majsterek, Ireneusz
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10648005/ https://www.ncbi.nlm.nih.gov/pubmed/37958470 http://dx.doi.org/10.3390/cancers15215297

Ejemplares similares

Targeting NLRP3-Mediated Neuroinflammation in Alzheimer’s Disease Treatment
por: Barczuk, Julia, et al.
Publicado: (2022)

GBA1 Gene Mutations in α-Synucleinopathies—Molecular Mechanisms Underlying Pathology and Their Clinical Significance
por: Granek, Zuzanna, et al.
Publicado: (2023)

IRE1α Inhibitors as a Promising Therapeutic Strategy in Blood Malignancies
por: Wiese, Wojciech, et al.
Publicado: (2022)

Inhibition of Protein Aggregation and Endoplasmic Reticulum Stress as a Targeted Therapy for α-Synucleinopathy
por: Siwecka, Natalia, et al.
Publicado: (2023)

The PERK-Dependent Molecular Mechanisms as a Novel Therapeutic Target for Neurodegenerative Diseases
por: Rozpędek-Kamińska, Wioletta, et al.
Publicado: (2020)

Molecular Mechanisms Underlying NMDARs Dysfunction and Their Role in ADHD Pathogenesis
por: Kuś, Justyna, et al.
Publicado: (2023)

The Structure, Activation and Signaling of IRE1 and Its Role in Determining Cell Fate
por: Siwecka, Natalia, et al.
Publicado: (2021)

The Genetic and Endoplasmic Reticulum-Mediated Molecular Mechanisms of Primary Open-Angle Glaucoma
por: Rozpędek-Kamińska, Wioletta, et al.
Publicado: (2020)

The Potential Role of Small-Molecule PERK Inhibitor LDN-0060609 in Primary Open-Angle Glaucoma Treatment
por: Rozpędek-Kamińska, Wioletta, et al.
Publicado: (2021)

Dual role of Endoplasmic Reticulum Stress-Mediated Unfolded Protein Response Signaling Pathway in Carcinogenesis
por: Siwecka, Natalia, et al.
Publicado: (2019)

The Cytotoxicity and Genotoxicity of Three Dental Universal Adhesives—An In Vitro Study
por: Wawrzynkiewicz, Adam, et al.
Publicado: (2020)

The Toxicity of Universal Dental Adhesives: An In Vitro Study
por: Wawrzynkiewicz, Adam, et al.
Publicado: (2021)

The Cytotoxicity and Genotoxicity of Bioactive Dental Materials
por: Kunert, Marta, et al.
Publicado: (2022)

Synthesis and Hemostatic Activity of New Amide Derivatives
por: Banach, Lukasz, et al.
Publicado: (2022)

PI3K/AKT/mTOR Pathway in Angiogenesis
por: Karar, Jayashree, et al.
Publicado: (2011)

Targeting PI3K/Akt/mTOR Signaling in Cancer
por: Porta, Camillo, et al.
Publicado: (2014)

PI3K/Akt/mTOR inhibitors in breast cancer
por: Lee, Joycelyn JX, et al.
Publicado: (2015)

Role of dual PI3/Akt and mTOR inhibition in Waldenstrom's Macroglobulinemia
por: Sacco, Antonio, et al.
Publicado: (2010)

Targeting the PI3K/Akt/mTOR Pathway – Beyond Rapalogs
por: Markman, Ben, et al.
Publicado: (2010)

AKTivation of PI3K/AKT/mTOR signaling pathway by KSHV
por: Bhatt, Aadra P., et al.
Publicado: (2013)

The Role of PI3K/Akt/mTOR Signaling in Gastric Carcinoma
por: Matsuoka, Tasuku, et al.
Publicado: (2014)

Targeting the PI3K-AKT-mTOR signaling network in cancer
por: Khan, Khurum H., et al.
Publicado: (2013)

Outlook on PI3K/AKT/mTOR inhibition in acute leukemia
por: Fransecky, Lars, et al.
Publicado: (2015)

PI3K/AKT/mTOR pathway in pulmonary carcinoid tumours
por: Zhang, Zixuan, et al.
Publicado: (2017)

Targeting the PI3K/Akt/mTOR Pathway in Hepatocellular Carcinoma
por: Sun, Eun Jin, et al.
Publicado: (2021)

PI3K/AKT/mTOR pathway in tumor progression of oligodendrogliomas
por: Lisi, Lucia
Publicado: (2020)

Roles of PI3K/AKT/mTOR Axis in Arteriovenous Fistula
por: Ratti, Stefano, et al.
Publicado: (2022)

PI3K/AKT/mTOR-Targeted Therapy for Breast Cancer
por: Zhu, Kunrui, et al.
Publicado: (2022)

The Paradox of Akt-mTOR Interactions
por: Vadlakonda, Lakshmipathi, et al.
Publicado: (2013)

The PI3K/AKT/mTOR Signaling Pathway Is Overactivated in Primary Aldosteronism
por: Su, Hengchuan, et al.
Publicado: (2013)

Therapeutic targets for cancer: Current concepts with PI 3-K, Akt, & mTOR
por: Maiese, Kenneth
Publicado: (2013)

PI3K/Akt/mTOR signaling pathway and targeted therapy for glioblastoma
por: Li, Xiaoman, et al.
Publicado: (2016)

Association of BAFF with PI3K/Akt/mTOR signaling in lupus nephritis
por: Ge, Fengmei, et al.
Publicado: (2017)

Targeting the PI3K/Akt/mTOR signalling pathway in Cystic Fibrosis
por: Reilly, R., et al.
Publicado: (2017)

Targeting PI3K/Akt/mTOR in AML: Rationale and Clinical Evidence
por: Darici, Salihanur, et al.
Publicado: (2020)

Targeting PI3K/AKT/mTOR Signaling Pathway in Breast Cancer
por: Li, Huayi, et al.
Publicado: (2021)

Drugging the PI3K/AKT/mTOR Pathway in ER+ Breast Cancer
por: Alves, Carla L., et al.
Publicado: (2023)

The Role of PI3K/AKT/mTOR Signaling in Hepatocellular Carcinoma Metabolism
por: Tian, Ling-Yu, et al.
Publicado: (2023)

Targeting EGFR/PI3K/AKT/mTOR Signaling in Hepatocellular Carcinoma
por: Bang, Jieun, et al.
Publicado: (2023)

Presence of both alterations in FGFR/FGF and PI3K/AKT/mTOR confer improved outcomes for patients with metastatic breast cancer treated with PI3K/AKT/mTOR inhibitors
por: Wheler, Jennifer J., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_vorrs268bhe1qe3nav0mk5iobi